Harbor stripe · Tide-ready shipping · Free over $75
Login Register
glp-1 obesity drug news today New weight-loss drugs surge in popularity amid surge in US, worldwide trim Novo Nordisk signs $285m Quantity:Monthly
glp-1 obesity drug news today New weight-loss drugs surge in popularity amid surge in US, worldwide trim Novo Nordisk signs $285m Quantity:Monthly
glp-1 obesity drug news today New weight-loss drugs surge in popularity amid surge in US, worldwide trim Novo Nordisk signs $285m Quantity:Monthly
glp-1 obesity drug news today New weight-loss drugs surge in popularity amid surge in US, worldwide trim Novo Nordisk signs $285m Quantity:Monthly
glp-1 obesity drug news today

glp-1 obesity drug news today New weight-loss drugs surge in popularity amid surge in US, worldwide trim Novo Nordisk signs $285m Quantity:Monthly

SKU: 15803344464

4.5
USD28.82 USD74.82

Pay in 4 interest-free payments of $7.21 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 20 - Sep 25

Description

glp-1 obesity drug news today New weight-loss drugs surge in popularity amid surge in US, worldwide trim Novo Nordisk signs $285m Quantity:Monthly

Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA - Pharmaceutical Technology

As a premier triple receptor agonist, this compound is studied for its simultaneous interaction with the Glucagon, GIP, and GLP-1 receptor pathways

trim

Quantity:Monthly

doi: 10.1016/j.ejphar.2016.11.028 87 HandayaningsihA-ETakahashiMFukuokaHIguchiGNishizawaHYamamotoMet al

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products